Skip to main content
. 2019 Jun 11;17(6):348. doi: 10.3390/md17060348

Table 1.

Changes in the body weight of rats in the different groups during the experimental period.

Groups Weight (g)
0 Weeks 4 Weeks 8 Weeks Weight Gain
Control 120.04 ± 4.66a 303.62 ± 10.43a 371.21 ± 14.01a 245.13 ± 9.00a
Model 125.19 ± 4.79a 267.32 ± 5.62b 308.56 ± 4.58e 189.36 ± 8.33f
HCaCO3 120.39 ± 9.22a 269.63 ± 14.27b 326.33 ± 19.47bcd 211.42 ± 9.63bcd
HGCa 122.70 ± 2.19a 271.54 ± 13.35b 331.92 ± 11.43bc 221.79 ± 10.96bc
LCPPH + LCaCO3 122.443 ± 4.75a 266.95 ± 11.27b 320.97 ± 14.36cde 196.53 ± 11.53ef
MCPPH + MCaCO3 119.72 ± 5.43a 271.54 ± 17.60b 328.01 ± 24.35bcd 208.23 ± 21.50cde
HCPPH + HCaCO3 123.94 ± 4.76a 269.85 ± 12.52b 333.47 ± 17.22bc 214.70 ± 11.34bcd
LCPPH-Ca 123.34 ± 4.49a 267.35 ± 9.50b 325.72 ± 20.89bcd 202.38 ± 17.97def
MCPPH-Ca 121.65 ± 4.63a 269.20 ± 6.67b 332.21 ± 11.45bc 204.33 ± 15.22de
HCPPH-Ca 121.85 ± 7.19a 270.62 ± 13.87b 340.02 ± 20.01a 223.41 ± 13.03b

Note: control, normal group; model, low calcium group; HCaCO3, high dosage of CaCO3 group; HGCa, high dosage of calcium gluconate group; LCPPH + LCaCO3, low dosage of CPPH supplemented with low dosage of CaCO3 group; MCPPH + MCaCO3, model dosage of CPPH supplemented with model dosage of CaCO3 group; HCPPH + HCaCO3, high dosage of CPPH supplemented with high dosage of CaCO3 group; LCPPH-Ca, low dosage of CPPH-Ca group; MCPPH-Ca, model dosage of CPPH-Ca group; HCPPH-Ca, high dosage of CPPH-Ca group. Data are expressed as the mean ± SD (n = 10). One-way ANOVA with Tukey’s test. Different letters indicate significant effect with p < 0.05.